4Therasse P,Arbuck SG,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors.European Organization for Research and Treatment of Cancer,National Cancer Institute Of the United States,National Cancer Institute of Canada.J Natl Cancer Inst,2000,92(3):205-216.
5Eiermann W,Paepke S,Appfelstaedt J,et al.Preoperative treatment of postmenopausal breast cancer patients with letrozole:A randomized double-blind multicenter study.Ann Oncol,2001,12:1527.
6Ellis MJ,Coop A,Singh B,et al.Letrozole is more effective ueoadjuvant endocrine therapy than tamoxifen for ErbB-1-and/or ErbB-2 positive.estrogen receptor-positive primary breast cancer:evidence from a phase m randomized trial.J Clin Oncol,2001,l9(18):3808-38l6.
7Dixon JM, Anderson TJ, Miller WR. Neoadiuvant endocrine therapy of breast cancer: a surgical perspective[J]. Eur J Cancer,2002,38(17) :2214-2221.
8Milla Santos A, Milla L,Calvo N, et al. Anastroloze as neoadjuvant therapy for patients with hormone-depend- ent, locally-advanced breast cancer. Anticancer Res [J]. 2004, 24(2C):1315-1318.
9Eiermann W, Paepke S, Appfelstaedt J, et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole., a randomized double-blind multicenter study[J]. Ann Oncol,2001,12(11) : 1527-1532.
10Dixon JM,Love CD,Bellamy CO,et al. Letrozole as primary medical therapy for locally advanced and large operable breast cancer[J]. Breast Cancer ResTreat,2001, 66(3):191-199.
